Alps Advisors Inc Arcturus Therapeutics Holdings Inc. Transaction History

Alps Advisors Inc

$17.8 Billion
Q3 2025

A detailed history of Alps Advisors Inc transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 13,101 shares of ARCT stock, worth $95,244. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,101

Previous 14,619 10.38%

Holding current value

$95,244

Previous $190,000 26.84%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 05, 2025	SELL	$11.39 - $22.17 $17,290 - $33,654	-1,518 Reduced 10.38%	13,101 $241,000
Q2 2025 Aug 11, 2025	SELL	$8.91 - $14.41 $47,490 - $76,805	-5,330 Reduced 26.72%	14,619 $190,000
Q1 2025 Apr 30, 2025	SELL	$10.59 - $20.83 $20,671 - $40,660	-1,952 Reduced 8.91%	19,949 $211,000
Q4 2024 Feb 13, 2025	BUY	$14.82 - $25.48 $933 - $1,605	63 Added 0.29%	21,901 $371,000
Q3 2024 Nov 12, 2024	SELL	$18.08 - $25.38 $149,648 - $210,070	-8,277 Reduced 27.48%	21,838 $506,000
Q2 2024 Aug 13, 2024	BUY	$24.35 - $44.39 $51,183 - $93,307	2,102 Added 7.5%	30,115 $733,000
Q1 2024 May 14, 2024	SELL	$31.23 - $42.99 $6,464 - $8,898	-207 Reduced 0.73%	28,013 $945,000
Q4 2023 Feb 14, 2024	SELL	$17.71 - $32.97 $37,244 - $69,335	-2,103 Reduced 6.94%	28,220 $889,000
Q3 2023 Nov 14, 2023	BUY	$25.44 - $37.35 $274,726 - $403,342	10,799 Added 55.31%	30,323 $774,000
Q2 2023 Aug 14, 2023	BUY	$23.94 - $32.36 $467,404 - $631,796	19,524 New	19,524 $559,000
Q3 2022 Nov 14, 2022	SELL	$13.05 - $22.13 $15,607 - $26,467	-1,196 Reduced 7.63%	14,481 $215,000
Q2 2022 Aug 11, 2022	SELL	$12.26 - $31.17 $140,070 - $356,117	-11,425 Reduced 42.16%	15,677 $247,000
Q1 2022 May 16, 2022	SELL	$17.64 - $39.57 $60,028 - $134,656	-3,403 Reduced 11.16%	27,102 $731,000
Q4 2021 Feb 09, 2022	SELL	$34.2 - $47.56 $59,986 - $83,420	-1,754 Reduced 5.44%	30,505 $1.13 Million
Q3 2021 Nov 15, 2021	SELL	$27.88 - $58.25 $67,079 - $140,149	-2,406 Reduced 6.94%	32,259 $1.54 Million
Q2 2021 Aug 11, 2021	BUY	$25.79 - $42.11 $894,010 - $1.46 Million	34,665 New	34,665 $1.17 Million
Q4 2020 Feb 03, 2021	SELL	$34.61 - $123.66 $1.08 Million - $3.85 Million	-31,101 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$37.49 - $63.19 $118,018 - $198,922	3,148 Added 11.26%	31,101 $1.33 Million
Q2 2020 Aug 05, 2020	BUY	$12.66 - $58.27 $353,884 - $1.63 Million	27,953 New	27,953 $1.31 Million

Others Institutions Holding ARCT

# of Institutions

174

Shares Held

26M

Call Options Held

2.32M

Put Options Held

866K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $193M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Arcturus Therapeutics Holdings Inc. Transaction History